Participate in Clinical Trials
Clinical trials are critical to making type 1 diabetes a condition of the past.
What are Clinical Trials?
Clinical trials advance treatments and care so people with type 1 diabetes (T1D) can live fuller, healthier lives.
For a treatment, drug, or device to make it into the hands of people with T1D, it must first complete a vital process: a series of clinical trials to ensure safety and efficacy.
Currently, there are over 300 clinical trials for T1D. Enrolling in these clinical trials is essential to our mission: Accelerating life-changing breakthroughs to cure, prevent, and treat type 1 diabetes and its complications.
We’re here to make it as easy as possible for every member of this incredible community to learn more about type 1 diabetes clinical trials and consider participation.
How to Participate in Clinical Trials
Despite how critical clinical trials are to finding therapies to cure, prevent, and treat T1D, many trials are delayed due to slow enrollment, which can hinder progress. Participating in a clinical trial is a great way to contribute to a future without T1D!

Visit our partners at Antidote to match with clinical trials you might be eligible for—all in under a minute.
Our Clinical Trial Education Volunteers (CTEVs) are highly trained to answer questions you may have or connect you to local clinical trial coordinators.
Our Participant Advisory Council promotes representation in clinical trials and ensures the participant’s voice is used to inform clinical trial design and implementation.
Sign up for our monthly research newsletter, The Pipeline, for the latest in type 1 diabetes science and clinical research.
Explore Current Clinical Trials
Learn about currently recruiting clinical trials for disease-modifying therapies, which may slow or stop T1D progression.
Learn about currently recruiting clinical trials for cell therapies.
Learn about currently recruiting clinical trials that are being conducted virtually.

Featured Clinical Trial: The POLARIS Study
Gentibio has initiated a phase 1 clinical trial (the POLARIS study) assessing the safety and tolerability of GNTI-122. This cell therapy—a one-time treatment—engineers a person’s own cells to counteract the autoimmune process, potentially slowing or stopping T1D progression.
To be eligible to participate, you must be between 18 to 45 years old, have been diagnosed with T1D within 120 days at the time of screening, and screen positive for a specific genetic marker.
This trial is enrolling in California, Massachusetts, New York, and North Carolina, and will soon be open sites in Florida. Learn more and see if you are eligible to participate by discussing with your healthcare provider or contacting the study sponsor.

We want every member of the diverse T1D community to be aware of clinical trials, how to participate, and where to find information. The next generation of breakthroughs depends on it!”
Clinical Trials FAQ
A clinical trial is a research study involving human volunteers that tries to answer a specific health question. Clinical trials closely monitor people’s progress as they take part in the study of an investigational drug, device, or method of treatment that has not been approved by the FDA for that specific indication. Carefully conducted clinical trials are the gold standard to find treatments that work. Whether it’s an everyday, over-the-counter treatment, or the latest and greatest medical device, it went through the rigorous testing process of a clinical trial.
- You may get access to new treatments and technologies not available to the public. You may also have access to top diabetes clinics and researchers while enrolled in the clinical trial.
- But one thing is certain: you will feel empowered knowing that your contribution to clinical research will help advance medical treatments and technologies for future generations!
There are many clinical trials that a person with long-standing T1D diagnosis can enroll in. Go to the Breakthrough T1D Clinical Trials Connection, and enter where you live, the distance you can travel, and other attributes to be matched with clinical trials that you may be eligible for. You can even get up-to-date information on new trials when you enter your email address. Find your local Breakthrough T1D CTEV to discuss clinical trials in your area or virtual trials
All clinical trials have guidelines, called eligibility criteria, about who can participate. The criteria are based on factors such as age, sex, stage of disease, previous treatment history, and other medical history. These criteria help to reduce the risk to an individual look at more specific groups of patients to ensure that the researchers will be able to answer the questions they plan to study. Not everyone who applies for a clinical trial will be able to participate.
In clinical trials, experimental drugs are often compared with placebos (a treatment with no therapeutic value) to evaluate the treatment’s effectiveness.
Breakthrough T1D has an easy-to-use tool called the Clinical Trials Connection, which asks users simple questions—about where they live, the distance they can travel, and other characteristics—to match them with trials for which they are eligible. Currently, there are more than 300 clinical trials for people living with T1D and T1D-related complications underway.
Currently, there are more than 300 clinical trials for people living with T1D and T1D-related complications under way.
Unfortunately, no. Many clinical trials are delayed or fail because doctors cannot find enough people to take part.
“Clinical trials are the only way to get to cures. The more folks that participate, the more data we have to improve and optimize treatment options.”
Marjorie
Clinical Trial Participant
Find Your Local Clinical Trial Education Volunteers
Our national team of Clinical Trial Education Volunteers (CTEVs) are highly trained to answer any questions you may have or introduce you to the clinical trial team near you.
Jude Restis: jrestis@yahoo.com
Laura Tremblay: ldtremblay71@gmail.com
Bithika Thompson: Thompson.Bithika@mayo.edu
Northern California:
Kim Fisher: kimfisherschwab@gmail.com
Joe Carlino: carlino1@earthlink.net
Vanessa Larco: vanessa.larco@gmail.com
Kirin Jamison: kirinj@gmail.com
Southern California:
Jeannette Hacker-Stratton: jstratton@coh.org
Allison Orechwa: allieot1d@gmail.com
Dawn Rosenblum: dawnrosenblumt1d@gmail.com
Meredith Coors: meredithcoors@gmail.com
Marjorie Lazarre: majorie.lazarre@ynhh.org
Ryan Chompre: rchompre@gmail.com
Atlanta area:
Kim Kukler: kimkukler@gmail.com
Other areas:
Holly Hailey: hollyhailey@comcast.net
Donny Harris: donnyharris1917@gmail.com
Tampa area:
Craig Bobik: cbobik32@gmail.com
Orlando and Jacksonville areas:
Anna Casu: anna.casu@adventhealth.com
Palm Beach:
Steve Fried: sfried1017@gmail.com
Mike Patipa: mpatipa@comcast.net
Stephanie Pfaff: Stephaniepfaff23@gmail.com
Arlene Stach: arlene.stach.t1d@gmail.com
Jamie Felton: jamifelt@iu.edu
Julie Coffey: julie-coffey@mchsi.com
Karissa Thompson: karissathompson1@gmail.com
Kelly Hoenig: kellyhoenig@gmail.com
Emily Rapp: emilybrapp@gmail.com
Jamie Felton: jamifelt@iu.edu
Amanda Gilchrist: Amandajgilchrist@gmail.com
Kristin Neff: kristin.neff@gmail.com
Sally Southard: ssouthardctev@gmail.com
Amanda Gilchrist: Amandajgilchrist@gmail.com
Kristin Neff: kristin.neff@gmail.com
Colleen Buggs-Saxton: cbuggs@med.wayne.edu
Mike Kay: kaymichael4@gmail.com
Jen Miner: jaminer1@yahoo.com
Meezan Hamzavi: meezan3304@gmail.com
Debbie Evans: debbieaevans1@gmail.com
Angie Grant: angie.grant.t1d@gmail.com
Emily Rapp: emilybrapp@gmail.com
Julie Geddes: juliebgeddes@gmail.com
Karissa Thompson: karissathompson1@gmail.com
Kelly Hoenig: kellyhoenig@gmail.com
Julie Coffey: julie-coffey@mchsi.com
Laura Brigham: Lbrigham52@gmail.com
Bithika Thompson: Thompson.Bithika@mayo.edu
Amanda Gilchrist: Amandajgilchrist@gmail.com
Kristin Neff: kristin.neff@gmail.com
Sumita Singh: singhsum@yahoo.com
Ryan Chompre: rchompre@gmail.com
Bithika Thompson: Thompson.Bithika@mayo.edu
Andrea Cawein: andicawein@gmail.com
Alecia Wesner: aleciawesner@gmail.com
Natasha Bolick: ngbolick@gmail.com
Tom Kern: Kern.thomas.f@gmail.com
Debbie Evans: debbieaevans1@gmail.com
Angie Grant: angie.grant.t1d@gmail.com
Ashley Hack: ashley.hack@gmail.com
Jen Miner (Northern Ohio): jaminer1@yahoo.com
Jude Restis: jrestis@yahoo.com
Laura Tremblay: ldtremblay71@gmail.com
Western and Central Pennsylvania:
Gina Leckie (Pittsburgh): rleckieT1Dphd@gmail.com
Jennifer Lieb (Harrisburg): jenniferalieb@gmail.com
Philadelphia:
Ryan Chompre: rchompre@gmail.com
Amanda Gilchrist: Amandajgilchrist@gmail.com
Kristin Neff: kristin.neff@gmail.com
Holly Hailey: hollyhailey@comcast.net
Donny Harris: donnyharris1917@gmail.com
Kim Kukler: kimkukler@gmail.com
Debbie Evans: debbieaevans1@gmail.com
Angie Grant: angie.grant.t1d@gmail.com
Chattanooga:
Priyanka Kalpande: priyanka.clinicaldata@gmail.com
Memphis:
Alana Altomare: altomarealana@gmail.com
Other areas:
Dongsoo Lee: dongsooleet1d@gmail.com
San Antonio:
Pam Banks: pambanks2004@gmail.com
Dallas/North Texas:
Mary Beth Cox: marybethcoxmd@gmail.com
Other areas:
Bonnie McCann-Crosby: BMMcCann@texaschildrens.org
Meredith Coors: meredithcoors@gmail.com
Amanda Gilchrist: Amandajgilchrist@gmail.com
Kristin Neff: kristin.neff@gmail.com
Sally Southard: ssouthardctev@gmail.com
Jude Restis: jrestis@yahoo.com
Laura Tremblay: ldtremblay71@gmail.com
Sally Southard: ssouthardctev@gmail.com
Rachel Fenske: fenske.breakthrought1d@gmail.com
Kari Weier: KWeier@uwhealth.org
Meredith Coors: meredithcoors@gmail.com
Participating in clinical trials has given me valuable insights into the latest T1D research and provided me with a strong sense of community.”
T1D Clinical Trials News
Cell Therapies Clinical Trials
Awareness Clinical Trials People and Leadership
Access and Affordability Advocacy Automated Insulin Delivery Systems Clinical Trials Medical Affairs National Diabetes Awareness Month Research Special Diabetes Program T1D Technology
Get the Latest Research News and Updates from Breakthrough T1D
Sign up for our monthly research newsletter, The Pipeline, to stay up to date on the latest in T1D science.


